Clinical Trials in Meldola, FC
17 recruiting
Showing 1–17 of 17 trials
Recruiting
Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC
HER2NSCLC (Advanced Non-small Cell Lung Cancer)
Gruppo Oncologico Italiano di Ricerca Clinica50 enrolled22 locationsNCT07356544
Recruiting
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Novartis Pharmaceuticals300 enrolled32 locationsNCT07093801
Recruiting
Phase 2
Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma
Soft Tissue SarcomaLeiomyosarcoma of Ovary
Italian Sarcoma Group100 enrolled17 locationsNCT04383119
Recruiting
Observational Study on Endometrial Stromal Tumors
Endometrial Stromal Tumors
Italian Sarcoma Group100 enrolled13 locationsNCT02829437
Recruiting
Phase 3
FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.
Colorectal, Cancer
Gruppo Oncologico del Nord-Ovest238 enrolled24 locationsNCT06733038
Recruiting
Phase 2
Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)
Prostate Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS70 enrolled2 locationsNCT05893381
Recruiting
Not Applicable
Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients
GlioblastomaIDH Wild-type and STAT3-positive Glioblastoma
Istituto Oncologico Veneto IRCCS110 enrolled16 locationsNCT06964815
Recruiting
An Observational Study on Epithelioid Sarcoma
Epithelioid Sarcoma
Italian Sarcoma Group100 enrolled11 locationsNCT03099681
Recruiting
Phase 1Phase 2
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.
Breast Cancer
Novartis Pharmaceuticals58 enrolled32 locationsNCT06247995
Recruiting
Phase 2
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
GlioblastomaVaccination
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS28 enrolled1 locationNCT04523688
Recruiting
Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)
Diffuse Large B Cell Lymphoma
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS300 enrolled4 locationsNCT04300101
Recruiting
"Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL
Leukemia, Lymphoblastic
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS60 enrolled3 locationsNCT06919393
Recruiting
Whole Body MRI in Oncology
Advanced Breast CancerAdvanced Prostate CancerMultiple Myeloma+3 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1,000 enrolled3 locationsNCT06895291
Recruiting
Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario
Ovarian Cancer
Consorzio Oncotech300 enrolled21 locationsNCT06836219
Recruiting
Phase 3
Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)
Carcinoma, Ovarian EpithelialLow Grade Serous Adenocarcinoma of Ovary
Ente Ospedaliero Ospedali Galliera132 enrolled19 locationsNCT05601700
Recruiting
Phase 2
Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.
Stage IV Colorectal CancerCurative Resection
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS19 enrolled2 locationsNCT02919644
Recruiting
Phase 2
A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.
Soft Tissue SarcomaNeuroendocrine TumorsVaccination+2 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS51 enrolled1 locationNCT04166006